影像组学与临床模型预测非典型导管增生升级并可能减少不必要的手术治疗
本研究回顾性纳入2015年1月至2023年5月在一家三级中心因微钙化簇行乳腺X线摄影和真空辅助乳腺活检诊断为非典型导管增生的患者,构建4个逻辑回归模型预测升级为癌的风险;最佳模型纳入全部数据,AUC为0.82(0.71-0.92),特异度为0.89(0.75,0.97),阴性预测值为0.92(0.78-0.98),提示影像组学联合临床数据可提高风险预测准确性并可能减少不必要的手术治疗。
要点
- 最佳模型(影像组学+临床)AUC 0.82(0.71-0.92),特异度0.89(0.75,0.97),NPV 0.92(0.78-0.98)。
- 临床特征模型AUC 0.72(0.60-0.84),影像组学特征模型AUC 0.73(0.61-0.85)。
- 影像组学特征联合「簇大小」和「年龄」将AUC提升至0.79(0.67-0.91)。
核心结论
- 影像组学可能作为减少「非典型导管增生升级低风险」患者不必要治疗的有价值工具,联合影像组学信息与临床数据提高了风险预测的准确性。
研究设计与样本
- 回顾性研究,纳入2015年1月至2023年5月一家三级中心行乳腺X线摄影和真空辅助乳腺活检诊断为非典型导管增生的微钙化簇患者143例共153个簇,以手术结局确定升级,样本分为107例训练集和46例测试集,构建4个逻辑回归模型。
诊断标准与关键数值
- 临床特征模型AUC 0.72(0.60-0.84);影像组学特征模型AUC 0.73(0.61-0.85);影像组学特征联合「簇大小」和「年龄」模型AUC 0.79(0.67-0.91);纳入全部数据的最佳模型AUC 0.82(0.71-0.92),特异度0.89(0.75,0.97),阴性预测值0.92(0.78-0.98)。
临床应用与阅片要点
- 研究显示影像组学联合临床数据可能提高预测非典型导管增生升级为癌的准确性,并可能减少被归类为「非典型导管增生升级低风险」患者的不必要治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To identify patients with atypical ductal hyperplasia (ADH) at low risk of upgrading to carcinoma. This study aims to assess the performance of radiomics combined with clinical factors to predict occult breast cancer among women diagnosed with ADH.
METHODS: This study retrospectively included microcalcification clusters of patients who underwent Mx and VABB with a diagnosis of ADH at a tertiary center from January 2015 to May 2023. Clinical and radiological data (age, cluster size, BI-RADS classification, mammographic density, breast cancer history, residual microcalcifications) were collected. Surgical outcomes were used to determine upgrade. Four logistic regression models were developed to predict the risk of upgrade. The performance was evaluated using the area under the receiver operating characteristic curve (AUC) and performance scores.
RESULTS: A total of 143 patients with 153 clusters were included. Twelve radiomic features and six clinical factors were selected for model development. The sample was split into 107 training and 46 test cases. Clinical features achieved an AUC of 0.72 (0.60-0.84), radiomic features an AUC of 0.73 (0.61-0.85). Radiomic features with "cluster size" and "age" improved the AUC to 0.79 (0.67-0.91). The best model, incorporating all data, achieved an AUC of 0.82 (0.71-0.92), a specificity of 0.89 (0.75, 0.97), and NPV of 0.92 (0.78-0.98).
CONCLUSION: This study demonstrates the potential of radiomic as a valuable tool for reducing unnecessary treatments for patient classified as "low risk of ADH upgrade". Combining radiomic information with clinical data improved the accuracy of risk prediction.
引用
- Brunetti N, Campi C, Biddau G, et al. Radiomic and clinical model for predicting atypical ductal hyperplasia upgrades and potentially reduce unnecessary surgical treatments. Eur J Radiol. 2024. PMID: 39454425. doi:10.1016/j.ejrad.2024.111799
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。